SkinBioTherapeutics(GB:SBTX)
GBX 4.000.00 (0.00%)
GB:SBTX
SkinBioTherapeutics financials statements
GBX 4.00
At close:0.00 (0.00%)
Want to see GB:SBTX full AI Analyst Report?
SkinBioTherapeutics (SBTX) Income Statement
26 Followers
SkinBioTherapeutics Income Statement
Last quarter (Q2 2025), SkinBioTherapeutics's total revenue was £2.17M, an increase of 1932.30% from the same quarter last year. In Q2, SkinBioTherapeutics's net income was £-794.26K. See SkinBioTherapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 |
|---|---|---|---|---|---|
| £ 4.64M | £ 1.21M | £ 132.06K | £ 74.76K | £ 0.00 | |
| £ 2.71M | £ 683.04K | £ 85.19K | £ 45.34K | £ -5.05K | |
| £ 3.53M | £ 3.59M | £ 3.08M | £ 3.03M | £ 1.49M | |
| Depreciation and Amortization | £ 426.60K | £ 175.97K | £ 44.19K | £ 29.67K | £ 5.05K |
| £ -196.54K | £ -2.72M | £ -2.96M | £ -2.95M | £ -1.49M | |
| £ -826.79K | £ -2.90M | £ -3.00M | £ -2.98M | £ -1.49M | |
| £ 111.67K | £ -43.76K | £ -8.89K | £ -10.13K | £ -3.68K | |
| £ -715.12K | £ -2.95M | £ -3.01M | £ -2.99M | £ -1.50M | |
| £ -696.25K | £ -2.88M | £ -2.84M | £ -2.79M | £ -1.43M | |
| Per Share Metrics | |||||
| Basic EPS | £ 0.00 | £ -0.02 | £ -0.02 | £ -0.02 | £ -0.01 |
| Diluted EPS | £ 0.00 | £ -0.02 | £ -0.02 | £ -0.02 | £ -0.01 |
| Weighted Average Shares Outstanding | 227.87M | 186.29M | 164.71M | 156.78M | 146.70M |
| Weighted Average Shares Outstanding (Diluted) | 227.87M | 186.29M | 164.71M | 156.78M | 146.70M |
Currency in GBP

